Industry Research Reports

Home > Reports > Service & Software > Global Tissue-Based Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Tissue-Based Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Service & Software

Published Date: 2025-02-21

Pages: 78 Pages

Report ld: 4147741

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Tissue-Based Diagnostics Market Size(US$)

CAGR 2025-2031

6.7%

Market Size,2031

USD 9,055

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 6,136 million

Market Forecast in 2031(Value)

US$ 9,055 million

CAGR

6.7%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Tissue-Based Diagnostics market size was US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Tissue-Based Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tissue-Based Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

MARKET SEGMENTATION

By Company

Roche
Danaher
Thermo Fisher Scientific
Abbott
Agilent Technologies
ABCAM
Merck
BD
Hologic
Bio Rad

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Digital Pathology and Workflow Management
Special Staining

Segment by Application

Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Tissue-Based Diagnostics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.

Chapter 3: Detailed analysis of Tissue-Based Diagnostics manufacturers competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Region analysis by company, by Type, by Application, revenue for each segment.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tissue-Based Diagnostics revenue, gross margin, and recent development, etc.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Immunohistochemistry (IHC)

1.2.3 In Situ Hybridization (ISH)

1.2.4 Digital Pathology and Workflow Management

1.2.5 Special Staining

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Research Laboratories

1.3.4 Pharmaceutical Companies

1.3.5 Contract Research Organizations

1.3.6 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tissue-Based Diagnostics Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Tissue-Based Diagnostics Revenue Market Share by Region (2020-2025)

2.4 Global Tissue-Based Diagnostics Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Tissue-Based Diagnostics Market Size and Prospective (2020-2031)

2.5.2 Europe Tissue-Based Diagnostics Market Size and Prospective (2020-2031)

2.5.3 China Tissue-Based Diagnostics Market Size and Prospective (2020-2031)

2.5.4 Japan Tissue-Based Diagnostics Market Size and Prospective (2020-2031)

2.5.5 Southeast Asia Tissue-Based Diagnostics Market Size and Prospective (2020-2031)

2.5.6 India Tissue-Based Diagnostics Market Size and Prospective (2020-2031)

2.5.7 Central & South America Tissue-Based Diagnostics Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Tissue-Based Diagnostics Historic Market Size by Type (2020-2025)

3.2 Global Tissue-Based Diagnostics Forecasted Market Size by Type (2026-2031)

3.3 Different Types Tissue-Based Diagnostics Representative Players

4 Breakdown Data by Application

4.1 Global Tissue-Based Diagnostics Historic Market Size by Application (2020-2025)

4.2 Global Tissue-Based Diagnostics Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Tissue-Based Diagnostics Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Tissue-Based Diagnostics Players by Revenue (2020-2025)

5.1.2 Global Tissue-Based Diagnostics Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Tissue-Based Diagnostics Revenue

5.4 Global Tissue-Based Diagnostics Market Concentration Analysis

5.4.1 Global Tissue-Based Diagnostics Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Tissue-Based Diagnostics Revenue in 2024

5.5 Global Key Players of Tissue-Based Diagnostics Head office and Area Served

5.6 Global Key Players of Tissue-Based Diagnostics, Product and Application

5.7 Global Key Players of Tissue-Based Diagnostics, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Tissue-Based Diagnostics Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Tissue-Based Diagnostics Market Size by Type (2020-2025)

6.1.2.2 North America Tissue-Based Diagnostics Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Tissue-Based Diagnostics Market Size by Application (2020-2025)

6.1.3.2 North America Tissue-Based Diagnostics Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Tissue-Based Diagnostics Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Tissue-Based Diagnostics Market Size by Type (2020-2025)

6.2.2.2 Europe Tissue-Based Diagnostics Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Tissue-Based Diagnostics Market Size by Application (2020-2025)

6.2.3.2 Europe Tissue-Based Diagnostics Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Tissue-Based Diagnostics Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China Tissue-Based Diagnostics Market Size by Type (2020-2025)

6.3.2.2 China Tissue-Based Diagnostics Market Share by Type (2020-2025)

6.3.3 China Market Size by Application

6.3.3.1 China Tissue-Based Diagnostics Market Size by Application (2020-2025)

6.3.3.2 China Tissue-Based Diagnostics Market Share by Application (2020-2025)

6.3.4 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments and Downstream

6.4.1 Japan Tissue-Based Diagnostics Revenue by Company (2020-2025)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Tissue-Based Diagnostics Market Size by Type (2020-2025)

6.4.2.2 Japan Tissue-Based Diagnostics Market Share by Type (2020-2025)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Tissue-Based Diagnostics Market Size by Application (2020-2025)

6.4.3.2 Japan Tissue-Based Diagnostics Market Share by Application (2020-2025)

6.4.4 Japan Market Trend and Opportunities

6.5 Southeast Asia Market: Players, Segments and Downstream

6.5.1 Southeast Asia Tissue-Based Diagnostics Revenue by Company (2020-2025)

6.5.2 Southeast Asia Market Size by Type

6.5.2.1 Southeast Asia Tissue-Based Diagnostics Market Size by Type (2020-2025)

6.5.2.2 Southeast Asia Tissue-Based Diagnostics Market Share by Type (2020-2025)

6.5.3 Southeast Asia Market Size by Application

6.5.3.1 Southeast Asia Tissue-Based Diagnostics Market Size by Application (2020-2025)

6.5.3.2 Southeast Asia Tissue-Based Diagnostics Market Share by Application (2020-2025)

6.5.4 Southeast Asia Market Trend and Opportunities

6.6 India Market: Players, Segments and Downstream

6.6.1 India Tissue-Based Diagnostics Revenue by Company (2020-2025)

6.6.2 India Market Size by Type

6.6.2.1 India Tissue-Based Diagnostics Market Size by Type (2020-2025)

6.6.2.2 India Tissue-Based Diagnostics Market Share by Type (2020-2025)

6.6.3 India Market Size by Application

6.6.3.1 India Tissue-Based Diagnostics Market Size by Application (2020-2025)

6.6.3.2 India Tissue-Based Diagnostics Market Share by Application (2020-2025)

6.6.4 India Market Trend and Opportunities

7 Key Players Profiles

7.1 Roche

7.1.1 Roche Company Details

7.1.2 Roche Business Overview

7.1.3 Roche Tissue-Based Diagnostics Introduction

7.1.4 Roche Revenue in Tissue-Based Diagnostics Business (2020-2025)

7.1.5 Roche Recent Development

7.2 Danaher

7.2.1 Danaher Company Details

7.2.2 Danaher Business Overview

7.2.3 Danaher Tissue-Based Diagnostics Introduction

7.2.4 Danaher Revenue in Tissue-Based Diagnostics Business (2020-2025)

7.2.5 Danaher Recent Development

7.3 Thermo Fisher Scientific

7.3.1 Thermo Fisher Scientific Company Details

7.3.2 Thermo Fisher Scientific Business Overview

7.3.3 Thermo Fisher Scientific Tissue-Based Diagnostics Introduction

7.3.4 Thermo Fisher Scientific Revenue in Tissue-Based Diagnostics Business (2020-2025)

7.3.5 Thermo Fisher Scientific Recent Development

7.4 Abbott

7.4.1 Abbott Company Details

7.4.2 Abbott Business Overview

7.4.3 Abbott Tissue-Based Diagnostics Introduction

7.4.4 Abbott Revenue in Tissue-Based Diagnostics Business (2020-2025)

7.4.5 Abbott Recent Development

7.5 Agilent Technologies

7.5.1 Agilent Technologies Company Details

7.5.2 Agilent Technologies Business Overview

7.5.3 Agilent Technologies Tissue-Based Diagnostics Introduction

7.5.4 Agilent Technologies Revenue in Tissue-Based Diagnostics Business (2020-2025)

7.5.5 Agilent Technologies Recent Development

7.6 ABCAM

7.6.1 ABCAM Company Details

7.6.2 ABCAM Business Overview

7.6.3 ABCAM Tissue-Based Diagnostics Introduction

7.6.4 ABCAM Revenue in Tissue-Based Diagnostics Business (2020-2025)

7.6.5 ABCAM Recent Development

7.7 Merck

7.7.1 Merck Company Details

7.7.2 Merck Business Overview

7.7.3 Merck Tissue-Based Diagnostics Introduction

7.7.4 Merck Revenue in Tissue-Based Diagnostics Business (2020-2025)

7.7.5 Merck Recent Development

7.8 BD

7.8.1 BD Company Details

7.8.2 BD Business Overview

7.8.3 BD Tissue-Based Diagnostics Introduction

7.8.4 BD Revenue in Tissue-Based Diagnostics Business (2020-2025)

7.8.5 BD Recent Development

7.9 Hologic

7.9.1 Hologic Company Details

7.9.2 Hologic Business Overview

7.9.3 Hologic Tissue-Based Diagnostics Introduction

7.9.4 Hologic Revenue in Tissue-Based Diagnostics Business (2020-2025)

7.9.5 Hologic Recent Development

7.10 Bio Rad

7.10.1 Bio Rad Company Details

7.10.2 Bio Rad Business Overview

7.10.3 Bio Rad Tissue-Based Diagnostics Introduction

7.10.4 Bio Rad Revenue in Tissue-Based Diagnostics Business (2020-2025)

7.10.5 Bio Rad Recent Development

8 Tissue-Based Diagnostics Market Dynamics

8.1 Tissue-Based Diagnostics Industry Trends

8.2 Tissue-Based Diagnostics Market Drivers

8.3 Tissue-Based Diagnostics Market Challenges

8.4 Tissue-Based Diagnostics Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Tissue-Based Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Tissue-Based Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Tissue-Based Diagnostics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Tissue-Based Diagnostics Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Tissue-Based Diagnostics Revenue Share by Region (2020-2025)

Table 6. Global Tissue-Based Diagnostics Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Tissue-Based Diagnostics Revenue Share Forecast by Region (2026-2031)

Table 8. Global Tissue-Based Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Tissue-Based Diagnostics Revenue Market Share by Type (2020-2025)

Table 10. Global Tissue-Based Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Tissue-Based Diagnostics Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Tissue-Based Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Tissue-Based Diagnostics Revenue Market Share by Application (2020-2025)

Table 15. Global Tissue-Based Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Tissue-Based Diagnostics Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Tissue-Based Diagnostics Application

Table 18. Global Tissue-Based Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Tissue-Based Diagnostics Market Share by Players (2020-2025)

Table 20. Global Top Tissue-Based Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tissue-Based Diagnostics as of 2024)

Table 21. Ranking of Global Top Tissue-Based Diagnostics Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Tissue-Based Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Tissue-Based Diagnostics, Headquarters and Area Served

Table 24. Global Key Players of Tissue-Based Diagnostics, Product and Application

Table 25. Global Key Players of Tissue-Based Diagnostics, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Tissue-Based Diagnostics Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Tissue-Based Diagnostics Revenue Market Share by Company (2020-2025)

Table 29. North America Tissue-Based Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Tissue-Based Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Tissue-Based Diagnostics Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Tissue-Based Diagnostics Revenue Market Share by Company (2020-2025)

Table 33. Europe Tissue-Based Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Tissue-Based Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Tissue-Based Diagnostics Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Tissue-Based Diagnostics Revenue Market Share by Company (2020-2025)

Table 37. China Tissue-Based Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Tissue-Based Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Tissue-Based Diagnostics Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Tissue-Based Diagnostics Revenue Market Share by Company (2020-2025)

Table 41. Japan Tissue-Based Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Tissue-Based Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 43. Southeast Asia Tissue-Based Diagnostics Revenue by Company (2020-2025) & (US$ Million)

Table 44. Southeast Asia Tissue-Based Diagnostics Revenue Market Share by Company (2020-2025)

Table 45. Southeast Asia Tissue-Based Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 46. Southeast Asia Tissue-Based Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 47. India Tissue-Based Diagnostics Revenue by Company (2020-2025) & (US$ Million)

Table 48. India Tissue-Based Diagnostics Revenue Market Share by Company (2020-2025)

Table 49. India Tissue-Based Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 50. India Tissue-Based Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 51. Roche Company Details

Table 52. Roche Business Overview

Table 53. Roche Tissue-Based Diagnostics Product

Table 54. Roche Revenue in Tissue-Based Diagnostics Business (2020-2025) & (US$ Million)

Table 55. Roche Recent Development

Table 56. Danaher Company Details

Table 57. Danaher Business Overview

Table 58. Danaher Tissue-Based Diagnostics Product

Table 59. Danaher Revenue in Tissue-Based Diagnostics Business (2020-2025) & (US$ Million)

Table 60. Danaher Recent Development

Table 61. Thermo Fisher Scientific Company Details

Table 62. Thermo Fisher Scientific Business Overview

Table 63. Thermo Fisher Scientific Tissue-Based Diagnostics Product

Table 64. Thermo Fisher Scientific Revenue in Tissue-Based Diagnostics Business (2020-2025) & (US$ Million)

Table 65. Thermo Fisher Scientific Recent Development

Table 66. Abbott Company Details

Table 67. Abbott Business Overview

Table 68. Abbott Tissue-Based Diagnostics Product

Table 69. Abbott Revenue in Tissue-Based Diagnostics Business (2020-2025) & (US$ Million)

Table 70. Abbott Recent Development

Table 71. Agilent Technologies Company Details

Table 72. Agilent Technologies Business Overview

Table 73. Agilent Technologies Tissue-Based Diagnostics Product

Table 74. Agilent Technologies Revenue in Tissue-Based Diagnostics Business (2020-2025) & (US$ Million)

Table 75. Agilent Technologies Recent Development

Table 76. ABCAM Company Details

Table 77. ABCAM Business Overview

Table 78. ABCAM Tissue-Based Diagnostics Product

Table 79. ABCAM Revenue in Tissue-Based Diagnostics Business (2020-2025) & (US$ Million)

Table 80. ABCAM Recent Development

Table 81. Merck Company Details

Table 82. Merck Business Overview

Table 83. Merck Tissue-Based Diagnostics Product

Table 84. Merck Revenue in Tissue-Based Diagnostics Business (2020-2025) & (US$ Million)

Table 85. Merck Recent Development

Table 86. BD Company Details

Table 87. BD Business Overview

Table 88. BD Tissue-Based Diagnostics Product

Table 89. BD Revenue in Tissue-Based Diagnostics Business (2020-2025) & (US$ Million)

Table 90. BD Recent Development

Table 91. Hologic Company Details

Table 92. Hologic Business Overview

Table 93. Hologic Tissue-Based Diagnostics Product

Table 94. Hologic Revenue in Tissue-Based Diagnostics Business (2020-2025) & (US$ Million)

Table 95. Hologic Recent Development

Table 96. Bio Rad Company Details

Table 97. Bio Rad Business Overview

Table 98. Bio Rad Tissue-Based Diagnostics Product

Table 99. Bio Rad Revenue in Tissue-Based Diagnostics Business (2020-2025) & (US$ Million)

Table 100. Bio Rad Recent Development

Table 101. Tissue-Based Diagnostics Market Trends

Table 102. Tissue-Based Diagnostics Market Drivers

Table 103. Tissue-Based Diagnostics Market Challenges

Table 104. Tissue-Based Diagnostics Market Restraints

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

List of Figures

Figure 1. Tissue-Based Diagnostics Product Picture

Figure 2. Global Tissue-Based Diagnostics Market Share by Type: 2024 VS 2031

Figure 3. Immunohistochemistry (IHC) Features

Figure 4. In Situ Hybridization (ISH) Features

Figure 5. Digital Pathology and Workflow Management Features

Figure 6. Special Staining Features

Figure 7. Global Tissue-Based Diagnostics Market Share by Application: 2024 VS 2031

Figure 8. Hospitals

Figure 9. Research Laboratories

Figure 10. Pharmaceutical Companies

Figure 11. Contract Research Organizations

Figure 12. Other

Figure 13. Tissue-Based Diagnostics Report Years Considered

Figure 14. Global Tissue-Based Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Tissue-Based Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Tissue-Based Diagnostics Revenue Market Share by Region: 2020 VS 2024

Figure 17. North America Tissue-Based Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. Europe Tissue-Based Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. China Tissue-Based Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Japan Tissue-Based Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Southeast Asia Tissue-Based Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. India Tissue-Based Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. Central & South America Tissue-Based Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. Global Tissue-Based Diagnostics Market Share by Players in 2024

Figure 25. Global Top Tissue-Based Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tissue-Based Diagnostics as of 2024)

Figure 26. The Top 10 and 5 Players Market Share by Tissue-Based Diagnostics Revenue in 2024

Figure 27. North America Tissue-Based Diagnostics Market Share by Type (2020-2025)

Figure 28. North America Tissue-Based Diagnostics Market Share by Application (2020-2025)

Figure 29. Europe Tissue-Based Diagnostics Market Share by Type (2020-2025)

Figure 30. Europe Tissue-Based Diagnostics Market Share by Application (2020-2025)

Figure 31. China Tissue-Based Diagnostics Market Share by Type (2020-2025)

Figure 32. China Tissue-Based Diagnostics Market Share by Application (2020-2025)

Figure 33. Japan Tissue-Based Diagnostics Market Share by Type (2020-2025)

Figure 34. Japan Tissue-Based Diagnostics Market Share by Application (2020-2025)

Figure 35. Southeast Asia Tissue-Based Diagnostics Market Share by Type (2020-2025)

Figure 36. Southeast Asia Tissue-Based Diagnostics Market Share by Application (2020-2025)

Figure 37. India Tissue-Based Diagnostics Market Share by Type (2020-2025)

Figure 38. India Tissue-Based Diagnostics Market Share by Application (2020-2025)

Figure 39. Roche Revenue Growth Rate in Tissue-Based Diagnostics Business (2020-2025)

Figure 40. Danaher Revenue Growth Rate in Tissue-Based Diagnostics Business (2020-2025)

Figure 41. Thermo Fisher Scientific Revenue Growth Rate in Tissue-Based Diagnostics Business (2020-2025)

Figure 42. Abbott Revenue Growth Rate in Tissue-Based Diagnostics Business (2020-2025)

Figure 43. Agilent Technologies Revenue Growth Rate in Tissue-Based Diagnostics Business (2020-2025)

Figure 44. ABCAM Revenue Growth Rate in Tissue-Based Diagnostics Business (2020-2025)

Figure 45. Merck Revenue Growth Rate in Tissue-Based Diagnostics Business (2020-2025)

Figure 46. BD Revenue Growth Rate in Tissue-Based Diagnostics Business (2020-2025)

Figure 47. Hologic Revenue Growth Rate in Tissue-Based Diagnostics Business (2020-2025)

Figure 48. Bio Rad Revenue Growth Rate in Tissue-Based Diagnostics Business (2020-2025)

Figure 49. Bottom-up and Top-down Approaches for This Report

Figure 50. Data Triangulation

Figure 51. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Tissue-Based Diagnostics market? zhanKai

The top companies in the global Tissue-Based Diagnostics market are Roche、Danaher、Thermo Fisher Scientific.

What is the annual compound growth rate of the global Tissue-Based Diagnostics market size from 2025 to 2031? shouQi

What was the global market size of Tissue-Based Diagnostics in 2031? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Tissue-Based Diagnostics in 2025? shouQi

Related Reports

Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 6136 million in 2025 and is projected to reach US$ 9601 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-07-09
Pages: 105
USD 3950.00
(Single User License)
Global Tissue-Based Diagnostics Market Research Report 2026
The global Tissue-Based Diagnostics market was valued at US$ 6136 million in 2025 and is anticipated to reach US$ 9601 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-04-21
Pages: 110
USD 2900.00
(Single User License)
Global Tissue-Based Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tissue-Based Diagnostics market is projected to grow from US$ 5787 million in 2024 to US$ 9055 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-25
Pages: 129
USD 4900.00
(Single User License)
Tissue-Based Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 99
USD 3950.00
(Single User License)
Global Tissue-Based Diagnostics Market Research Report 2025
The global market for Tissue-Based Diagnostics was valued at US$ 5787 million in the year 2024 and is projected to reach a revised size of US$ 9055 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published Date: 2025-02-21
Pages: 72
USD 2900.00
(Single User License)
Global Tissue-Based Diagnostics Market Insights, Forecast to 2030
Market Analysis and Insights: Global Tissue-Based Diagnostics Market
Published Date: 2024-04-08
Pages: 110
USD 4900.00
(Single User License)
Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5321 million in 2023 and is forecast to a readjusted size of US$ 8054.2 million by 2030 with a CAGR of 6.7% during the forecast period 2024-2030
Published Date: 2024-02-22
Pages: 110
USD 3950.00
(Single User License)
Global Tissue-Based Diagnostics Market Research Report 2024
The global Tissue-Based Diagnostics market was valued at US$ 5321 million in 2023 and is anticipated to reach US$ 8054.2 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
Published Date: 2024-02-06
Pages: 81
USD 2900.00
(Single User License)

Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 6136 million in 2025 and is projected to reach US$ 9601 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-07-09
Pages: 105
USD 3950.00 (Single User License)
Global Tissue-Based Diagnostics Market Research Report 2026
The global Tissue-Based Diagnostics market was valued at US$ 6136 million in 2025 and is anticipated to reach US$ 9601 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-04-21
Pages: 110
USD 2900.00 (Single User License)
Global Tissue-Based Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tissue-Based Diagnostics market is projected to grow from US$ 5787 million in 2024 to US$ 9055 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-25
Pages: 129
USD 4900.00 (Single User License)
Tissue-Based Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 99
USD 3950.00 (Single User License)
Global Tissue-Based Diagnostics Market Research Report 2025
The global market for Tissue-Based Diagnostics was valued at US$ 5787 million in the year 2024 and is projected to reach a revised size of US$ 9055 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-02-21
Pages: 72
USD 2900.00 (Single User License)
Global Tissue-Based Diagnostics Market Insights, Forecast to 2030
Market Analysis and Insights: Global Tissue-Based Diagnostics Market
Published: 2024-04-08
Pages: 110
USD 4900.00 (Single User License)
Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5321 million in 2023 and is forecast to a readjusted size of US$ 8054.2 million by 2030 with a CAGR of 6.7% during the forecast period 2024-2030
Published: 2024-02-22
Pages: 110
USD 3950.00 (Single User License)
Global Tissue-Based Diagnostics Market Research Report 2024
The global Tissue-Based Diagnostics market was valued at US$ 5321 million in 2023 and is anticipated to reach US$ 8054.2 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
Published: 2024-02-06
Pages: 81
USD 2900.00 (Single User License)